Loading...

Home
Stock
ERNA

ERNA News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ERNA News

Ernexa's Innovative Advances in Ovarian Cancer Treatment

1d agoNewsfilter

Ernexa Therapeutics Reports Significant Loss Narrowing in Q1

May 12 2026stocktwits

Ernexa's Innovative Advances in Ovarian Cancer Treatment

May 11 2026Newsfilter

Ernexa Therapeutics Exceeds Expectations with Promising Therapy Results

May 06 2026stocktwits

Ernexa Therapeutics Reports Breakthrough in Cancer Treatment

May 06 2026Newsfilter

Ernexa Therapeutics to Implement 1-for-25 Reverse Stock Split

Apr 30 2026seekingalpha

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Apr 30 2026seekingalpha

Ernexa Implements 1-for-25 Reverse Stock Split

Apr 30 2026Newsfilter

ERNA Events

Eterna Therapeutics Trading Halted

Eterna Therapeutics trading halted, volatility trading pause

Eterna Therapeutics Trading Halted

Eterna Therapeutics trading halted, volatility trading pause

ERNA Monitor News

Ernexa Therapeutics Reports Significant Loss Narrowing in Q1

Ernexa's ERNA-101 Shows Promising Results in Ovarian Cancer Treatment

Ernexa Reports Loss Narrowing and Promising ERNA-101 Results

Ernexa Therapeutics Reports Breakthrough in Cancer Treatment

Ernexa Therapeutics Reports Breakthrough in Cancer Treatment

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Ernexa Therapeutics Inc. stock rises significantly

Ernexa Therapeutics to Host Investor Webcast on February 25

ERNA Earnings Analysis

No Data

No Data

People Also Watch